Top Health Care Stocks:
Leading health care stocks were flat to higher in Monday's pre-bell trading.
Stocks moving on news include:
(-) Assembly Biosciences (ASMB), which was plunging by more than 25% as it reported results from two phase 2a clinical trials of ABI-H0731, a novel antiviral in development for the treatment of chronic hepatitis B virus infection. Data from the studies showed that faster and deeper declines in HBV DNA and HBV RNA were possible when combined with nucleos(t)ide therapies, the company said.
(-) Aphria (APHA) was falling by more than 11% as the cannabis company posted a fiscal Q3 loss of $0.20 per share, compared to earnings of $0.08 per share in the same period a year ago. Analysts polled by Capital IQ expected a loss of $0.04 per share.
(-) Clovis Oncology (CLVS) was down more than 10% after saying it will discontinue its sponsored phase 2 clinical trial of rucaparib for recurrent, metastatic bladder cancer.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.